NO308992B1 - Aminoguanidinkarboksylater og anvendelse av disse for fremstilling av et medikament for behandling av ikke- insulinavhengig diabetes mellitus - Google Patents

Aminoguanidinkarboksylater og anvendelse av disse for fremstilling av et medikament for behandling av ikke- insulinavhengig diabetes mellitus Download PDF

Info

Publication number
NO308992B1
NO308992B1 NO972346A NO972346A NO308992B1 NO 308992 B1 NO308992 B1 NO 308992B1 NO 972346 A NO972346 A NO 972346A NO 972346 A NO972346 A NO 972346A NO 308992 B1 NO308992 B1 NO 308992B1
Authority
NO
Norway
Prior art keywords
aminoiminomethyl
hydrazino
dihydrazinomethylene
mmol
acid
Prior art date
Application number
NO972346A
Other languages
English (en)
Norwegian (no)
Other versions
NO972346L (no
NO972346D0 (no
Inventor
Scott D Larsen
Valerie A Vaillancourt
Paul D May
Steven P Tanis
John A Tucker
Martin D Meglasson
Heinrich J Schostarez
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/484,547 external-priority patent/US5994577A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO972346D0 publication Critical patent/NO972346D0/no
Publication of NO972346L publication Critical patent/NO972346L/no
Publication of NO308992B1 publication Critical patent/NO308992B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO972346A 1994-11-23 1997-05-22 Aminoguanidinkarboksylater og anvendelse av disse for fremstilling av et medikament for behandling av ikke- insulinavhengig diabetes mellitus NO308992B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34427494A 1994-11-23 1994-11-23
US08/484,547 US5994577A (en) 1994-11-23 1995-06-07 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
PCT/US1995/014126 WO1996016031A1 (en) 1994-11-23 1995-11-13 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus

Publications (3)

Publication Number Publication Date
NO972346D0 NO972346D0 (no) 1997-05-22
NO972346L NO972346L (no) 1997-07-23
NO308992B1 true NO308992B1 (no) 2000-11-27

Family

ID=26993832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972346A NO308992B1 (no) 1994-11-23 1997-05-22 Aminoguanidinkarboksylater og anvendelse av disse for fremstilling av et medikament for behandling av ikke- insulinavhengig diabetes mellitus

Country Status (24)

Country Link
US (2) US6166080A (de)
EP (1) EP0793646B1 (de)
JP (1) JPH10509455A (de)
CN (2) CN1097580C (de)
AT (1) ATE205188T1 (de)
AU (1) AU705893B2 (de)
BR (1) BR9509741A (de)
CA (1) CA2202265A1 (de)
CZ (1) CZ288597B6 (de)
DE (2) DE793646T1 (de)
DK (1) DK0793646T3 (de)
EE (1) EE03392B1 (de)
ES (1) ES2163531T3 (de)
FI (1) FI972185L (de)
GE (1) GEP20002026B (de)
HU (1) HUT77133A (de)
MX (1) MX9703807A (de)
NO (1) NO308992B1 (de)
NZ (1) NZ297604A (de)
PL (1) PL184614B1 (de)
PT (1) PT793646E (de)
RU (1) RU2162462C2 (de)
SK (1) SK282357B6 (de)
WO (1) WO1996016031A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526331D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel method
WO1997044324A1 (en) 1996-05-21 1997-11-27 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
CA2280871A1 (en) * 1997-02-13 1998-08-20 Valerie Piercy Use of nitric oxide synthase inhibitors for the treatment of diabetes
SE9702457D0 (sv) * 1997-06-26 1997-06-26 Pharmacia & Upjohn Ab Screening
US6001578A (en) * 1997-06-26 1999-12-14 Pharmacia & Upjohn Ab Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity
US6169115B1 (en) 1998-05-22 2001-01-02 Rima Kaddurah-Daouk Use of aminoguanidine analogs for the treatment of diseases of the nervous system
US6288124B1 (en) 1998-05-22 2001-09-11 Rima Kaddurah-Daouk Methods of inhibiting undesirable cell growth using an aminoguanidine compound
US6815421B1 (en) * 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
EP2283349A1 (de) * 2008-04-29 2011-02-16 Becton, Dickinson & Company Verfahren und system zur messung einer probe für die bestimmung des vorliegens und gegebenenfalls behandlung eines krankheitszustands
CN102159539B (zh) * 2008-06-26 2014-04-16 矽烷实验室股份公司 用于血糖控制的新型二甲双胍甘氨酸盐
GB201300435D0 (en) * 2013-01-10 2013-02-27 Medical Res Council Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
JP6121638B2 (ja) * 2015-04-23 2017-04-26 三菱瓦斯化学株式会社 ガス発生剤、及びそれを用いた発泡体の製造方法
US20170056352A1 (en) * 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
JP2023505687A (ja) 2019-12-11 2023-02-10 インスピルナ，インコーポレーテッド 癌の処置方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412105A (en) 1966-01-05 1968-11-19 American Home Prod beta-aryl-n-guanidino-beta-alanines
US3943253A (en) * 1974-06-27 1976-03-09 Barer Sol J Guanido acids as fungicides
JPS54128523A (en) 1978-03-29 1979-10-05 Nippon Carbide Ind Co Ltd 3-guanidinoamino propionic acid and its preparation
US5272165A (en) * 1984-03-19 1993-12-21 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
US5130324A (en) * 1984-03-19 1992-07-14 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
IT1201511B (it) 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
US5059712A (en) 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
EP0793646A1 (de) 1997-09-10
CZ136997A3 (cs) 1998-02-18
SK282357B6 (sk) 2002-01-07
DE793646T1 (de) 1999-12-30
NZ297604A (en) 2000-07-28
FI972185A7 (fi) 1997-05-22
PL320361A1 (en) 1997-09-29
CZ288597B6 (cs) 2001-07-11
FI972185A0 (fi) 1997-05-22
JPH10509455A (ja) 1998-09-14
GEP20002026B (en) 2000-04-10
EP0793646B1 (de) 2001-09-05
AU705893B2 (en) 1999-06-03
WO1996016031A1 (en) 1996-05-30
EE03392B1 (et) 2001-04-16
DK0793646T3 (da) 2001-12-17
NO972346L (no) 1997-07-23
FI972185L (fi) 1997-05-22
AU4279696A (en) 1996-06-17
NO972346D0 (no) 1997-05-22
MX9703807A (es) 1997-08-30
BR9509741A (pt) 1997-10-21
RU2162462C2 (ru) 2001-01-27
CA2202265A1 (en) 1996-05-30
DE69522580D1 (de) 2001-10-11
SK64097A3 (en) 1997-11-05
DE69522580T2 (de) 2002-10-10
EE9700094A (et) 1997-10-15
ATE205188T1 (de) 2001-09-15
PL184614B1 (pl) 2002-11-29
CN1377642A (zh) 2002-11-06
ES2163531T3 (es) 2002-02-01
CN1097580C (zh) 2003-01-01
HUT77133A (hu) 1998-03-02
CN1164226A (zh) 1997-11-05
US6166080A (en) 2000-12-26
PT793646E (pt) 2002-03-28
US6329545B1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
CA2029420C (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
EP0793646B1 (de) Carboxylierte aminoguanidine zur behandlung von insulin-unabhängigem diabetes mellitus
DE60121294T2 (de) Dihydro-1,3,5-triazinaminderivate und ihre therapeutischen verwendungen
AU664710B2 (en) A method for treatment of metabolic disorders
JPH06506455A (ja) 神経伝達物質放出調節剤としてのグアニジン置換体及びその誘導体ならびに神経伝達物質放出遮断物質を同定するための新規な方法
EP1435930A2 (de) Glykierungsinhibitoren zur prävention von komplikationen des alters, der diabetes und des rauchens
MXPA97003807A (en) Carboxylates of aminoguanidine for the treatment of the diabetes mellitus not dependent of the insul
EP2260022B1 (de) Substituierte cyclohexyldiamine
US5994577A (en) Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
JP2000502684A (ja) Ｎ―アシルアミノアルキルヒドラジンカルボキシイミダミド類
DK157813B (da) Analogifremgangsmaade til fremstilling af n-(4-aminobenzoyl)-n'-benzyl bispidinderivater
MXPA02011160A (es) Inhibidores del transporte de fosfato.
US5955617A (en) Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
US4233310A (en) Antiarteriosclerotic N-(mercaptoacyl)-histidines
US20020082448A1 (en) Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
US4206231A (en) Hypoglycaemically active 2-alkyl- or -alkenyl-hydrazono propionic acid derivatives
DE69813354T2 (de) Mittel zur Behandlung von Herzkrankheiten
WO1992011234A1 (de) Neue amine, verfahren zu ihrer herstellung, sowie diese verbindungen enthaltende arzneimittel
DE2146861C3 (de) N- [4-(ß-o-Anisamidö -äthyO-benzolsulfonyl] -N"cyclopentylcarbamid und Verfahren zu seiner Herstellung
DE69626307T2 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
CA2852214A1 (fr) Derives aminosteroidiens anti-diabetiques
DE2146861B2 (de) N- eckige klammer auf 4-(ss- spitze klammer auf o-anisamido spitze klammer zu -aethyl)-benzolsulfonyl eckige klammer zu -n'-cyclopentylcarbamid und verfahren zu seiner herstellung